- Report
- April 2024
- 500 Pages +
Global
From €3839EUR$3,995USD£3,282GBP
- Report
- July 2023
- 179 Pages
Global
From €4324EUR$4,500USD£3,697GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4756EUR$4,950USD£4,066GBP
- Report
- October 2020
- 156 Pages
Global
From €1321EUR$1,375USD£1,130GBP
€2642EUR$2,750USD£2,259GBP
- Report
- April 2023
- 278 Pages
Global
From €4782EUR$5,151USD£3,950GBP
- Report
- July 2018
- 77 Pages
Global
From €5717EUR$5,950USD£4,888GBP
- Report
- June 2022
- 135 Pages
Global
From €2162EUR$2,250USD£1,848GBP
- Report
- April 2023
- 164 Pages
Global
From €9128EUR$9,500USD£7,804GBP
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,161GBP
- Report
- August 2022
- 30 Pages
Global
From €2642EUR$2,750USD£2,259GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,245GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,245GBP
- Report
- July 2021
- 50 Pages
China
From €2498EUR$2,600USD£2,136GBP
- Report
- January 2019
- 82 Pages
Global
From €9608EUR$10,000USD£8,215GBP
- Report
- August 2022
United States
From €1864EUR$1,940USD£1,594GBP
- Report
- August 2022
Global
From €1047EUR$1,090USD£895GBP
- Report
- August 2021
Europe
From €3286EUR$3,420USD£2,809GBP
- Report
- August 2021
Global
From €3834EUR$3,990USD£3,278GBP
- Report
- February 2021
Global
From €2844EUR$2,960USD£2,432GBP
- Report
- February 2023
- 59 Pages
Global
From €3839EUR$3,995USD£3,282GBP
The Lupus Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for autoimmune diseases such as lupus. Lupus is a chronic, autoimmune disorder that can cause inflammation, pain, and tissue damage in various parts of the body. Lupus drugs are used to reduce inflammation, suppress the immune system, and reduce the risk of organ damage. These drugs are typically prescribed in combination with other treatments such as lifestyle changes, physical therapy, and other medications.
The Lupus Drug market is highly competitive, with a range of products available from both generic and branded manufacturers. Companies in the market include AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Novartis, Pfizer, and Roche. Show Less Read more